Synlett 2013; 24(5): 550-569
DOI: 10.1055/s-0032-1318138
account
© Georg Thieme Verlag Stuttgart · New York

Recent Progress in the Chemistry of Mucohalic Acids: Versatile Building Blocks in Organic Synthesis

Ji Zhang*
Research API, Pfizer Global Research and Development, Ann Arbor Laboratories, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA   Fax: +86(769)85370223   Email: zhangji@hecpharm.com   Email: jizhang009@yahoo.com
,
Koushik Das Sarma
Research API, Pfizer Global Research and Development, Ann Arbor Laboratories, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA   Fax: +86(769)85370223   Email: zhangji@hecpharm.com   Email: jizhang009@yahoo.com
,
Timothy T. Curran
Research API, Pfizer Global Research and Development, Ann Arbor Laboratories, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA   Fax: +86(769)85370223   Email: zhangji@hecpharm.com   Email: jizhang009@yahoo.com
› Author Affiliations
Further Information

Publication History

Received: 05 November 2012

Accepted after revision: 09 January 2013

Publication Date:
25 February 2013 (online)


Dedicated to the Ann Arbor Laboratories of Parke-Davis/Pfizer where Lipitor and Lyrica were invented and developed.

Abstract

This account documents our recent progress in exposing some of the potential of mucohalic acids in synthetic applications. Understanding their stability and reactivity in different reaction media allows the development of mild and regioselective methods to access various substituted butenolides, butenolactams, and 4,5-di­halopyridazin-3(2H)-ones and to create other novel, multifunctionalized building blocks.

1 Introduction

2 The Rationale for the Reinvestigation of Mucohalic Acid Chemistry

3 Understanding the Stability of Mucohalic Acids

4 One-Pot Synthesis of a 4,5-Dihalopyridazin-3(2H)-one and the Process Chemistry of ABT-963

5 Reductive Amination of Mucochloric Acid and Synthesis of Antiseizure Drug Levetiracetam (Keppra)

6 Reduction of Mucohalic Acids and Synthesis of Anti-­inflammatory Agent Rofecoxib (Vioxx)

7 Lewis Acid Catalyzed Knoevenagel Aldol Reaction

8 Lewis and Brønsted Acid Promoted Friedel–Crafts ­Hydroxyalkylation

9 Lewis Acid Facilitated Mukaiyama Aldol Reaction

10 Indium-Mediated Allylation in Water

11 Palladium-Free Regioselective Etherification and Amination

12 Novel Building Blocks Derived from Mucohalic Acids

13 Direct Vinylogous Aldol Addition Using α,β-Dihalo-­Substituted Butenolides and Butenolactams

14 Other Applications

15 Summary and Conclusion

 
  • References

    • 1a Jackson O. Am. Chem. J. 1881; 3: 4
    • 1b Allen C. Org. Synth. 1955; 3: 621
    • 1c Limpricht H. Justus Liebigs Ann. Chem. 1873; 165: 253
  • 2 Wasserman HH, Precopio FM. J. Am. Chem. Soc. 1952; 74: 326
  • 3 Hill HB, Jackson OR. Am. Chem. J. 1890; 12: 37
  • 4 Simonis H. Ber. Dtsch. Chem. Ges. 1899; 32: 2085
  • 5 Dury K. Angew. Chem. 1960; 72: 864
  • 6 Sulikowski GA, Agnelli F, Corbett RM. J. Org. Chem. 2000; 65: 337
    • 7a Wasserman HH, Precopio FM, Lin T.-C. J. Am. Chem. Soc. 1953; 75: 2527
    • 7b Wasserman HH, Precopio FM, Liu T.-C. J. Am. Chem. Soc. 1952; 74: 4093
    • 7c Wasserman HH, Precopio FM. J. Am. Chem. Soc. 1954; 76: 1242
    • 8a Mowry DT. J. Am. Chem. Soc. 1953; 75: 1909
    • 8b Mowry DT. J. Am. Chem. Soc. 1950; 72: 2535
    • 9a Duczek W, Jähnisch K. Synthesis 1992; 935
    • 9b Duczek W, Jähnisch K, Kunath A, Reck G, Winter G, Schulz B. Liebigs Ann. Chem. 1992; 8: 781
    • 10a Lattmann E, Sattayasai N, Niamsanit S, Dunn S. Bioorg. Med. Chem. Lett. 2005; 15: 919
    • 10b Lattmann E, Sattayasai N, Schwalbe CS, Niamsanit S, Billington DC, Lattmann P, Langley CA, Singh H, Dunn S. Curr. Drug. Discovery Technol. 2006; 3: 125

      For reviews, see:
    • 12a Cunha S, Oliveira CC. Quim. Nova 2011; 34: 1425
    • 12b Bellina F, Rossi R. Curr. Org. Chem. 2004; 12: 1089
    • 13a Ma S.-M, Yu Z.-Q. Org. Lett. 2003; 5: 2581
    • 13b Ma S.-M, Duan D.-H, Shi Z.-J. Org. Lett. 2000; 2: 1419
    • 13c Ma S.-M, Xie H.-X. Org. Lett. 2000; 2: 3801
    • 13d Ma S.-M, Yu Z.-Q. Org. Lett. 2003; 5: 1507
    • 13e Chen G.-F, Zeng R, Gu Z.-H, Fu C.-L, Ma S.-M. Org. Lett. 2008; 10: 4235
    • 13f Li S.-H, Ma S.-M. Org. Lett. 2011; 13: 6046
  • 14 Zhang J, Morton HE, Ji J. Tetrahedron Lett. 2006; 47: 8733
  • 15 Jähnisch K, Duczek W. J. Prakt. Chem. 1990; 332: 117
  • 16 Kerdesky FA, Leanna MR, Zhang J, Li W, Lallaman JE, Ji J, Morton HE. Org. Process Res. Dev. 2006; 10: 512
    • 17a Lattmann E, Kinchington D, Dunn S, Singh H, Ayuko WO, Tisdale MJ. J. Pharm. Pharmacol. 2004; 56: 1163
    • 17b Duczek W, Jähnisch K, Kunath A, Reck G, Winter G, Schulz B. Liebigs Ann. Chem. 1992; 8: 781
    • 18a Silverman RB. J. Med. Chem. 2012; 55: 567
    • 18b Silverman RB. Angew. Chem. Int. Ed. 2008; 47: 3500
  • 19 Zhang J, Blazecka PG, Davidson JG. Org. Lett. 2003; 5: 553
  • 20 Das Sarma K, Zhang J, Huang Y, Davidson JG. Eur. J. Org. Chem. 2006; 3730
  • 21 Zhang J, Blazecka PG, Belmont D, Davidson JG. Org. Lett. 2002; 4: 4559
  • 22 Zhang J, Das Sarma K, Curran TT, Belmont DT, Davidson JG. J. Org. Chem. 2005; 70: 5890
    • 23a Gathergood N, Zhuang W, Jørgensen KA. J. Am. Chem. Soc. 2000; 122: 12517
    • 23b Majer J, Kwiatkowski P, Jurczak J. Org. Lett. 2011; 13: 5944
    • 23c Ghosh AK, Martyr CD, Xu C.-X. Org. Lett. 2012; 14: 2002
  • 24 Zhang J, Blazecka PG, Curran TT. Tetrahedron Lett. 2007; 48: 2611
  • 25 Angell P, Zhang J, Belmont D, Curran T, Davidson JG. Tetrahedron Lett. 2005; 46: 2029
  • 26 Zhang J, Blazecka PG, Berven H, Belmont D. Tetrahedron Lett. 2003; 44: 5579
  • 27 Blazecka PG, Belmont D, Curran T, Pflum D, Zhang J. Org. Lett. 2003; 5: 5015
  • 28 Zhang J, Das Sarma K, Curran TT. Tetrahedron Lett. 2005; 46: 6433
  • 29 Das Sarma K, Zhang J, Curran TT. J. Org. Chem. 2007; 72: 3311
  • 30 Ube H, Shimada N, Terada M. Angew. Chem. Int. Ed. 2010; 49: 1858
  • 31 Luo J, Wang H, Han X, Xu L.-W, Kwiatkowski J, Huang K.-W, Lu Y.-X. Angew. Chem. Int. Ed. 2011; 50: 1861
  • 32 Guo Y.-L, Bai J.-F, Peng L, Wang L.-L, Jia L.-N, Luo X.-Y, Tian F, Xu X.-Y, Wang L.-X. J. Org. Chem. 2012; 77: 8338
  • 33 Gomez-Paloma L, Aquino M, Bruno I. Org. Lett. 2006; 8: 4831
  • 34 Guerrero MD, Aquino M, Bruno I, Terencio MC, Paya M, Riccio R, Gomez-Paloma L. J. Med. Chem. 2007; 50: 2176
  • 35 Humphries P, Oliver RM. Tetrahedron Lett. 2009; 50: 2682
  • 36 Frolov EB, Lakner FJ, Khvat AV, Ivachtchenko AV. Tetrahedron Lett. 2004; 45: 4693
  • 37 Dyck B, Markison S, Zhao L, Tamiya J, Grey J, Rowbottom MW, Zhang M, Vickers T, Sorensen K, Norton C, Wen J, Heise CE, Saunders J, Conlon P, Madan A, Schwarz D, Goodfellow VS. J. Med. Chem. 2006; 49: 3753
  • 38 Qian W, Winternheimer D, Allen J. Org. Lett. 2011; 13: 1682
  • 39 O’Dwyer EE, Mullane NS, Smyth TP. J. Heterocycl. Chem. 2011; 48: 286
  • 40 Tan Y.-H, Li J.-X, Xue F.-L, Qi J, Wang Z.-Y. Tetrahedron 2012; 68: 2827
  • 41 Wei M.-X, Feng L, Li X.-Q, Zhou X.-Z, Shao Z.-H. Eur. J. Med. Chem. 2009; 44: 3340
  • 42 Ren J, Ma D.-D, Sha Y, Li F, Cheng M.-S. Heterocycles 2010; 81: 1427
  • 43 Cunha S, Oliveira CC, Sabino JR. J. Braz. Chem. Soc. 2011; 22: 598